Clinical Trials on Salmonella Infections in Belgium

Total 1428 results

Sanofi

Terminated

Hydroxychloroquine in Outpatient Adults With COVID-19

Coronavirus Infection

United States, Belgium, France, Netherlands
GlaxoSmithKline

Completed

Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults

Tuberculosis

Belgium
GlaxoSmithKline

Completed

Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women

Respiratory Syncytial Virus Infections

Belgium
University Ghent
Merck Sharp & Dohme LLC; the Flanders Institute for Biotechnology

Completed

Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation (GO-GUT)

Axial Spondyloarthritis

Belgium
GlaxoSmithKline

Completed

Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults

Pneumococcal Disease

Belgium
Minervax ApS
Iqvia Pty Ltd

Completed

Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants

Group B Streptococcal Infections

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.

Tuberculosis (TB)

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years

Clostridium Infections

Belgium
GlaxoSmithKline
Aeras

Completed

Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

Tuberculosis

Belgium
Centre Hospitalier Universitaire Saint Pierre

Suspended

Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph Nodes

Tuberculosis

Belgium
GlaxoSmithKline

Completed

Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.

Prophylactic Pneumococcal Diseases

Belgium
University Hospital, Ghent
Universitair Ziekenhuis Brussel

Completed

Pharmacokinetics of Ciprofloxacin in Pediatric Patients

Urinary Tract Infection | Pyelonephritis

Belgium
GlaxoSmithKline

Completed

Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults

Infections, Streptococcal

Belgium
GlaxoSmithKline

Completed

Evaluation of Pneumococcal Vaccine Formulations in Young Adults

Infections, Streptococcal

Belgium
Beneo-Institute
European Union; Laboratorios Ordesa

Completed

Long-term Safety and Efficacy of Prebiotic Enriched Infant Formula

Healthy | Microbial Colonization | Infection

Spain, Belgium
Bactiguard AB

Completed

VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUs (VITAL)

Ventilator-associated Pneumonia

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients

Gram-Positive Bacterial Infections

Belgium
Polichem S.A.

Completed

Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population

Onychomycosis

Belgium, Germany, Italy, Latvia, Spain
GlaxoSmithKline

Completed

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

Hepatitis B

Belgium
University Hospital, Ghent
Hoffmann-La Roche

Completed

The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial

Cytomegalovirus Infections

Belgium
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline
Region of Wallonia; Public Private Partnership with Institute for Medical Immunology...

Completed

Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System

Hepatitis B

Belgium
Institute of Tropical Medicine, Belgium
Sciensano; Military Hospital, Brussels

Completed

Simplifying the Rabies Pre-exposure Vaccination

Rabies

Belgium
Centre Hospitalier Universitaire Saint Pierre

Completed

Induced Sputum Versus Bronchoscopy in Smear Negative Pulmonary Tuberculosis

Pulmonary Tuberculosis

Belgium
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults

Infections, Staphylococcal

Belgium
GlaxoSmithKline

Completed

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

Whooping Cough

Belgium
GlaxoSmithKline

Completed

Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population

Prophylaxis Invasive Pneumococcal Diseases and Pneumonia

Belgium
Brugmann University Hospital

Completed

Prevalence and Screening of Hepatitis C in Belgium in 2015

Hepatitis C

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Coagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus Infections

Infective Endocarditis | Necrotizing Fasciitis

Belgium
Sciensano

Completed

COVID-19 Vaccination Uptake in Belgium : Sociodemographic and Socioeconomic Disparities

COVID-19

Belgium
Cliniques universitaires Saint-Luc- Université...
Society for Anesthesia and Resuscitation of Belgium

Completed

Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals (COVID)

COVID-19

Belgium
Jessa Hospital
Hasselt University; University Hospital, Antwerp

Active, not recruiting

Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients (MIA-COVID-19)

COVID-19

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19) (REASSURE)

Covid19

Belgium
Brugmann University Hospital

Completed

Are Surgeons Ready to Get the COVID-19 Vaccine?

Covid19

Belgium
Tibotec Pharmaceuticals, Ireland

Completed

TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients

Hepatitis C

Belgium
Jessa Hospital

Completed

Predictive Value of SOFA and APACHE Scores for In-hospital Mortality in COVID-19 ICU Patients

Covid19

Belgium
Regeneron Pharmaceuticals

Completed

A Trial to Learn if a COVID-19 Therapeutic is Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants

Healthy

Belgium
Sciensano
Institute of Tropical Medicine, Belgium; Erasme University Hospital; Mensura...

Completed

COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine (REDU-VAC)

Covid19

Belgium
Universiteit Antwerpen
Vrije Universiteit Brussel; Université Libre de Bruxelles; Sciensano

Active, not recruiting

Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium (PREGCOVAC)

Covid19

Belgium
University of Liege
Laboratoires SMB S.A.

Completed

Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection

Covid19

Belgium
Murielle Surquin

Completed

Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age

Covid19

Belgium

3

Subscribe